Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Diabetes|June 6, 2026
Focusing on Diastolic Dysfunction to Achieve Consensus With the Term Diabetic CardiomyopathyAlexa N King, John R UssherExpert Review of Cardiovascular Therapy|February 21, 2014
The role of cardiac lipotoxicity in the pathogenesis of diabetic cardiomyopathyJohn R UssherEndocrine Reviews|February 11, 2012
Cardiovascular biology of the incretin systemJohn R Ussher, Daniel J DruckerNature Reviews. Cardiology|March 28, 2023
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of actionJohn R Ussher, Daniel J DruckerBasic Research in Cardiology|February 27, 2009
Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusionJohn R Ussher, Gary D LopaschukCardiovascular Research|May 24, 2008
The malonyl CoA axis as a potential target for treating ischaemic heart diseaseJohn R Ussher, Gary D LopaschukCirculation Research|May 24, 2014
Cardiovascular actions of incretin-based therapiesJohn R Ussher, Daniel J DruckerBiochimica Et Biophysica Acta|February 23, 2016
Lipotoxicity in obesity and diabetes-related cardiac dysfunctionIgor Zlobine, Keshav Gopal, John R UssherNutrients|October 14, 2023
Exogenous Ketone Supplementation and Ketogenic Diets for Exercise: Considering the Effect on Skeletal Muscle MetabolismHannah Khouri, John R Ussher, Céline AguerPeptides|September 19, 2018
Glucagon-like peptide-1 receptor action in the vasculatureMalak Almutairi, Rami Al Batran, John R UssherPageof 13